CARS2 Hypermethylation Is a Risk Factor for Stage B Heart Failure and Hospitalizations in the Project Baseline Health Study.
Publication
, Preprint
Regan, JA; Franklin, J; Kottilil, K; Cauwenberghs, N; Mahaffey, KW; Douglas, PS; Rodriguez, F; Haddad, F; Hernandez, AF; Shah, SH; Kwee, LC ...
May 3, 2025
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Regan, J. A., Franklin, J., Kottilil, K., Cauwenberghs, N., Mahaffey, K. W., Douglas, P. S., … Project Baseline Health Study Group. (2025). CARS2 Hypermethylation Is a Risk Factor for Stage B Heart Failure and Hospitalizations in the Project Baseline Health Study. https://doi.org/10.1101/2024.12.20.24319449
Regan, Jessica A., Jordan Franklin, Kalyani Kottilil, Nicholas Cauwenberghs, Kenneth W. Mahaffey, Pamela S. Douglas, Fatima Rodriguez, et al. “CARS2 Hypermethylation Is a Risk Factor for Stage B Heart Failure and Hospitalizations in the Project Baseline Health Study.,” May 3, 2025. https://doi.org/10.1101/2024.12.20.24319449.
Regan JA, Franklin J, Kottilil K, Cauwenberghs N, Mahaffey KW, Douglas PS, et al. CARS2 Hypermethylation Is a Risk Factor for Stage B Heart Failure and Hospitalizations in the Project Baseline Health Study. 2025.
Regan, Jessica A., et al. CARS2 Hypermethylation Is a Risk Factor for Stage B Heart Failure and Hospitalizations in the Project Baseline Health Study. 3 May 2025. Pubmed, doi:10.1101/2024.12.20.24319449.
Regan JA, Franklin J, Kottilil K, Cauwenberghs N, Mahaffey KW, Douglas PS, Rodriguez F, Haddad F, Hernandez AF, Shah SH, Kwee LC, Project Baseline Health Study Group. CARS2 Hypermethylation Is a Risk Factor for Stage B Heart Failure and Hospitalizations in the Project Baseline Health Study. 2025.